Dr. Dineli Wickramasinghe has over 20 years of biotech industry experience. Currently as founding partner at DWSO Biopharma Consulting, she advises venture capital firms, investors, biotech startups, in addition to biopharma company CEO, executive leadership and review boards.
Previously, Dr. Wickramasinghe was Chief Scientific Officer at Affinita Biosciences and held senior leadership positions at 23andMe and Amgen (including site head at Amgen San Francisco) developing both protein and small molecule therapeutics. Prior to that, she led oncology teams at Genentech and BASF BioResearch, in addition to being an adjunct faculty and post-doc mentor.
Dr. Wickramasinghe has a B.A. from Mount Holyoke College in Massachusetts and a Ph.D. from Tufts University in Boston. She completed her post-doctoral fellowship in molecular genetics at the National Cancer Institute. She has authored numerous peer reviewed scientific publications, book reviews and presented at national and international conferences. She is an inventor on multiple patents.